Trust and Transparency Noom is one of the most recognized names in digital weight loss
For injectable GLP-1 medications currently in use , patients should be aware of common side effects including nausea, vomiting, diarrhea, and decreased appetite, particularly during dose escalation
However, when you look closer, many of the claims made are unverified , unrealistic , or flat-out misleading
Gastroenterology 2023;165(2):499501.e4
To view a copy of this licence, visit About this article Cite this article Zheng, Z., Zong, Y., Ma, Y
Notably, the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, the first dedicated kidney outcome trial evaluating canagliflozin in people with type 2 diabetes mellitus and CKD, demonstrated a substantial reduction in the risk of kidney events [46]